We are independent & ad-supported. We may earn a commission for purchases made through our links.

Advertiser Disclosure

Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.

How We Make Money

We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently from our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Refractory Cancer?

Mary McMahon
By
Updated May 17, 2024
Our promise to you
WiseGEEK is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At WiseGEEK, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Refractory cancer is a cancer that is not responding to treatments. Individuals with cases of refractory cancer can be provided with supportive care to help them feel more comfortable, but their treatment options have been exhausted. Since new treatments are often in development, patients with this diagnosis may be able to find a clinical trial or apply for compassionate use of medications to try another treatment option that would not otherwise be available. Care for such patients is supervised by an oncologist, a medical specialist who focuses on cancer care.

For some refractory cancers, the cancer resists treatment from the start. Various treatment protocols may be tried, but the cancer is resistant to all of them. These cancers will not shrink or break up in response to chemotherapy and radiation, and either cannot be operated on or return after surgery. A diagnosis of refractory cancer can be made by examining medical imaging studies to see if the cancer is shrinking or changing shape in response to the treatments.

In other cases, a cancer responds to treatment initially, but stops responding partway through treatment. Patients with this form of refractory cancer may initially improve before the cancer returns and stubbornly resists treatments. In these patients, scans from various stages of treatment can be compared to see how the cancer is responding and to identify the point when the cancer stopped being susceptible to treatment.

If a patient has a cancer that is unresponsive to treatment and all traditional treatment avenues have been pursued, an oncologist may recommend the patient for clinical trials. Clinical trials provide access to medications in development and may offer opportunities to the patient. Certain trials actively seek out patients with refractory cancer. Patients can also look up clinical trial databases to see if there are any ongoing trials they can enroll in.

Treatment is also provided to manage symptoms. Cancer can be painful and a patient with refractory cancer will be provided with pain medication to increase comfort. Other medications and treatments can address symptoms like loss of appetite, anxiety, nausea, difficulty breathing, and organ failure. Some patients prefer to receive supportive treatments at home with the assistance of a home care nurse while others may prefer to be hospitalized or housed in a hospice facility. As new treatment options arise, patients can be presented with them to determine if they are interested in pursuing new treatments for their cancers.

WiseGEEK is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Mary McMahon
By Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a WiseGEEK researcher and writer. Mary has a liberal arts degree from Goddard College and spends her free time reading, cooking, and exploring the great outdoors.

Discussion Comments

By jholcomb — On Jun 15, 2011

@robbie21 - I think so, pretty much. Lung, breast, prostate, etc. There's no good kind of cancer, but there are worse kinds, and this is about as bad as it gets.

My favorite aunt died of refractory breast cancer and it was incredibly lonely for her. So much breast cancer information is geared toward "survivors." It's all pink ribbons and cancer walks and relentless cheerfulness. Well, she wasn't a "survivor." She was dying of it. She felt like even other cancer patients didn't want to be around her.

No one knows what to say to a person whose condition isn't responding to treatment and who just isn't going to get better, especially, I think, with the whole culture that surrounds breast cancer in particular.

By robbie21 — On Jun 14, 2011

I thought treatment of cancer had gotten pretty good in recent years. It seems like you hear about a lot of people making a complete recovery--except for the ones that don't. Can refractory cancer occur with any type of cancer?

Mary McMahon

Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a...

Read more
WiseGEEK, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGEEK, in your inbox

Our latest articles, guides, and more, delivered daily.